Mesothelin-targeted CAR-T cells for adoptive cell therapy of solid tumors

Significant progresses have been made in adoptive cell therapy with CAR-T cells for cancers, especially for hematological malignancies. However, the treatment of solid tumors still poses a tremendous challenge and remains an unmet medical need. Several factors are held responsible for the inadequate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Gui-Zhen, Li, Tian-Fang, Han, Shuang-Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
State of the Art Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425252/
https://www.ncbi.nlm.nih.gov/pubmed/34522250
http://dx.doi.org/10.5114/aoms.2019.84888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425252/
https://www.ncbi.nlm.nih.gov/pubmed/34522250
http://dx.doi.org/10.5114/aoms.2019.84888

Ejemplares similares